These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1666094

  • 1. Feline leukemia virus vaccine development.
    Sebring RW, Chu HJ, Chavez LG, Sandblom DS, Hustead DR, Dale B, Wolf D, Acree WM.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1413-9. PubMed ID: 1666094
    [No Abstract] [Full Text] [Related]

  • 2. Review of the first feline leukemia virus vaccine.
    Pollock VH, Haffer KN.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1406-9. PubMed ID: 1666092
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of a whole killed feline leukemia virus vaccine.
    York SM, York CJ.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1419-22. PubMed ID: 1666095
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibody response of kittens after vaccination followed by exposure to feline leukemia virus-infected cats.
    Hawks DM, Legendre AM, Rohrbach BW, Sebring R, Chavez L, Chu HJ, Acree WM.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1463-9. PubMed ID: 1666104
    [Abstract] [Full Text] [Related]

  • 10. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
    Lehmann R, Franchini M, Aubert A, Wolfensberger C, Cronier J, Lutz H.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1446-52. PubMed ID: 1666101
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of three commercial feline leukemia virus vaccines against methylprednisolone acetate-augmented oronasal challenge exposure with virulent virus.
    Pedersen NC, Johnson L.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1453-5. PubMed ID: 1666102
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.
    Grosenbaugh DA, Leard T, Pardo MC.
    J Am Vet Med Assoc; 2006 Mar 01; 228(5):726-7. PubMed ID: 16506935
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Manufacturer addresses concerns about FIV vaccine.
    Connell S.
    J Am Vet Med Assoc; 2003 Jan 15; 222(2):149. PubMed ID: 12555972
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously.
    Grosenbaugh DA, Leard T, Pardo MC, Motes-Kreimeyer L, Royston M.
    Vet Ther; 2004 Jan 15; 5(4):258-62. PubMed ID: 15719325
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.